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Internet Transparency of Local Men’s Health Clinics in Nebraska
Abstract
An overview of Men’s Health Clinics offering Testosterone Therapy in a Midwest State.
Introduction/ Background – Since 2001, there has been a 300% increase in the use of Testosterone
therapy. However, there remains limited published data on the demographics of facilities and providers
that advertise this service. This study aims to look at such demographics of advertised Men’s health
clinics in Nebraska.
Methods/ Materials – An internet search was conducted with the phrases “Nebraska Male health clinics,
Nebraska Low T/testosterone, Nebraska Hormone Replacement Therapy”. All clinics that were found
offering Testosterone therapy with Men’s health in their mission statement were included. Data was
gathered using 6 questions, with answers obtained from the public website or by calling the office.
Results – 19 different facilities were found that self-identified as Men’s Health clinics. 5/19 facilities were
nationally corporate owned, 13/19 were individually owned, and 1 was an academic university. All offered
Testosterone Therapy. Of the 19 facilities, 10/19 branded themselves primarily as Men’s Health Clinics. 6/
10 out of those offered testosterone therapy, Plasma infusion, and Penile Shockwave Therapy. Those that
offered services other than Men’s health were marketed as Medical Spas and Aesthetic centers, offering
hormone replacement therapy, aesthetics, and anti-aging treatments. 10/19 Clinics had no MD listed and
visits would be with a mid-level provider (NP or PA). Only 1/19 provided prices online, others required
consultation before prices would be given. Of the 19 facilities, only 6 accept insurance and the rest are
cash-pay clinics only.
Conclusions – Of the Nebraska clinics that self-identify as men’s health clinics, many are individually
owned clinics with a focus on hormone replacement or aesthetics. Of those clinics, many were run
entirely by mid-levels or with a supervising MD overseeing mid-levels. Less than 1/3rd of facilities accept
insurance and there is a lack of price transparency.
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Abstract

Introduction: Since 2001, there has been
a 300% increase in the use of testosterone
therapy. However, there remains limited
published data on the organizational structure
of the facilities and demographics of the
providers that offer this service. This study
aims to look at the structure and provider
demographics of advertised men’s health
clinics in Nebraska.
Methods: An internet search was conducted
with the phrases “Nebraska male health
clinics, Nebraska low T/testosterone,
Nebraska hormone replacement therapy.” All
clinics that were found offering testosterone
therapy with men’s health in their mission
statement were included. Data were gathered
using six questions, with answers obtained
from the public website or by calling the
office.
Results: Nineteen different facilities were
found that self-identified as men’s health
clinics. Five out of the nineteen facilities were
owned by national corporate entities, 13/19
were individually owned, and one was located
at an academic university. All facilities offered
testosterone therapy. Of the 19 facilities,
10/19 branded themselves primarily as men’s
health clinics of which six offered testosterone
therapy, plasma infusion, and penile
shockwave therapy. Ten out of the 19 clinics
had no MD listed and visits were with an
advanced practice provider (NP or PA). Only
1/19 provided prices online; whereas, others
required consultation before prices would be
given. Of the 19 facilities, only six accepted
insurance.
Conclusions: Of the Nebraska clinics that
self-identify as men’s health clinics, many are
individually owned clinics. Of those clinics,
over half were run entirely by advanced
practice providers or with a supervising MD
overseeing them. Less than one-third of
facilities accept insurance and there is a lack
of price transparency.

Introduction

Hypogonadism is a clinical condition defined
as low levels of serum testosterone associated
with specific signs and symptoms.1 When
hypogonadism occurs in an older male, the
condition is termed late onset hypogonadism
(LOH). Common symptoms include decreased
muscle mass and strength, increase in central
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body fat, loss of libido, memory loss, and
difficulty in concentration. However, these
symptoms can be hard to differentiate from
regular aging associated symptoms. The
American Urological Association guideline
states that clinical hypogonadism is defined as
serum testosterone levels lower than 300ng/
dl and treatment is clinically appropriate for
any levels below this threshold.2 Treatment
is in the form of prescription testosterone
therapy (TTh), where extraneous testosterone
hormone is introduced to the body to raise
serum testosterone to a recommended
level.3 Current methods include intradermal
injections, transdermal patches, sub dermal
pellets, or nasal application.
Prescription TTh remains a prevalent topic
of discussion throughout the world. In the
United States, the general public is exposed
to an array of radio, television and internet
advertisements, which is likely the major
factor contributing to the 300% increase
in testosterone use in men from 2002 to
2013.4 Studies have shown that this increase
in prescribing has been accompanied by
increases in testosterone level testing,
prescriptions of testosterone without the
full diagnostic evaluation recommended
by clinical practice guidelines and use
of testosterone for unproven conditions.5
Hundreds of men’s health clinics have
opened to accompany this trend, marketing
themselves in several ways to appeal to
consumers.6 Alongside TTh, many of these
clinics offer experimental non-FDA approved
therapies such as penile shockwave therapy
and plasma infusion, with claims they boost
sexual libido and overall well-being. These
experimental therapies have not been studied
rigorously and there is no scientific literature
proving their efficacy.7
Patients increasingly rely on the internet to
answer their health-related questions.8 In
addition, small studies reveal that people
generally consider attributes such as
professional design, ease of use and scientific
touch when assessing the credibility of
medical information online, and disregard
disclaimers and disclosure statements.9 The
increase in use of the internet by the public,
along with the potentially poor ability to
distinguish between credible and misleading
information underscores the need for more
rigorous research surrounding how online
marketing may impact the patient’s view on
health-related matters.

We conducted an exploratory study to
determine what information is available online
for patients seeking treatment at a men’s
health clinic in Nebraska. To our knowledge,
no previous studies have been performed that
evaluate the structure of men’s health clinics,
or demographics of providers working in
these clinics. We also sought to determine the
types of providers and therapies offered in
these clinics.

Methods
We identified men’s health clinics in the
State of Nebraska using Google incognito
internet search with the phrases “Nebraska
male health clinics, Nebraska Low T/
testosterone, Nebraska Hormone Replacement
Therapy.” All clinics that were found offering
testosterone therapy were reviewed. Data
were gathered using six predetermined
domains, with answers obtained from the
public website or by calling the clinic directly
for any information not available online.
Transparency was measured by whether the
information was publicly available online
or over the phone. Clinics with multiple
locations were treated as a single clinic for the
analysis.

Results
Nineteen different facilities were found that
self-identified as men’s health clinics. Of
these 5/19 facilities were owned by national
corporate entities, 13/19 were individually
owned, and 1 was located at an academic
university (our own institution) (Figure 1).
On their websites, 19/19 listed services
provided, 17/19 listed providers, and 1/19
listed prices for treatment. All of the identified
men’s health clinics offered Testosterone
Replacement Therapy. Of the 19 facilities,
10/19 branded themselves primarily as
men’s health clinics of which six offered
testosterone therapy, plasma infusion for
erectile dysfunction, and penile shockwave
therapy (Figure 2). Those that offered services
other than Men’s health were marketed as
medical spas and aesthetic centers, offering
hormone replacement therapy, aesthetics, and
anti-aging treatments. Regarding provider
workforce, 10/19 clinics had no physician
listed and visits were with an advance practice
provider (NP or PA) (Figure 3). Seventeen of
the 19 clinics listed provider qualifications
on the website and the other two clinics were
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transparent of provider qualifications over the
phone. Only 1/19 provided prices online while
the others required consultation before prices
would be given. Information about insurance
was posted online for 13/19 clinics. Of the 19
facilities, only six accepted insurance and the
rest are cash-pay clinics only.

Demographics
5%

26%

Discussion
Since, the early 2000’s, there has been a
dramatic increase in testosterone prescription
for TTh. In the decade from 2001 through
2011, testosterone prescriptions tripled from
0.81% to 2.91% of all men over 40, of which
many did not have a clear clinical reason.1,6
Studies have shown that the major reasons
for the increase is due to Direct to consumer
advertising and non-FDA approved Late
Onset Hypogonadism (LOH), which lacks
clinical evidence.10
Of the facilities offering testosterone therapy
in Nebraska, we found the majority were
clinics branded as Men’s testosterone clinics
or Men’s health clinics with a primary focus
on hormone replacement therapy and the
rest as aesthetic centers or medical spas. Of
these facilities, 13/19 were individual private
clinics with only 1 academic center found
to offer TTh. Many of the facilities were
staffed primarily with advanced practice
providers such as NPs or PAs with or without
a supervising physician. All were very
transparent about provider qualifications.
We also found that there exists a lack of price
transparency for services offered by most
clinics. Only 1/19 of the facilities had prices
listed on their website. The other clinics had
no prices listed on their website and declined
to provide price of treatment over the phone.
Other reviews of Male clinics have found that
costs for TTh can be up to $400 monthly.12 In
addition, two-thirds of the facilities are cashpay only, with no price transparency until
after the initial exam and testing. In a study
of primary care clinics, 60% provided cost
estimates of the initial visit, showing that it is
possible to provide this to interested patients.13
The out of pocket financial costs of TTh can
be significant, but there exists a lack of data
on safety and efficacy of male health clinics.
The main concern with centers that monetize
TTh is whether they are listening to the
entirety of the patient’s symptoms, discussing
lifestyle modifications, and properly treating
the patient’s condition. Previous studies of
TTh clinic websites have shown that they
promote the benefits of TTh while neglecting
to mention the risks.14
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Figure 1. Ownership demographics of men’s health clinics in Nebraska.
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Figure 2. Treatments offered by men’s health clinics in Nebraska.
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Figure 3. Degree of the medical provider at the men’s health clinic.
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The American Urological Association
currently defines hypogonadism as
testosterone <300 ng/dl. They recommend
treating hypogonadism until serum
testosterone is in the range of 450-600 ng/dl,
but many clinics advertise recommend raising
testosterone levels to much higher levels.15 In
2014, The FDA added a black box warning of
cardiovascular risks with TTh and rebranded
the indication to pathological hypogonadism
in an effort to prevent unnecessary
prescribing, which led to a decrease in
testosterone prescription from 2013 – 2016.
Unfortunately, it appears that many clinics
are still using the FDA off-label Late Onset
Hypogonadism (LOH) as justification for
TTh.16 Many of the male health clinics are
also advertising on their websites nonFDA approved plasma infusion and penile
shockwave therapy, which has no clinical
evidence to demonstrate its efficacy. The
Sexual Medicine Society of North America
considers these experimental therapies and
should be restricted to clinical trial research.17
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